Navigation Links
AMRI Launches SMARTSOURCING™ For Contract Manufacturing and Research Services
Date:4/30/2012

ALBANY, N.Y., April 30, 2012 /PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today SMARTSOURCING™, an approach that further focuses its research and contract manufacturing services on the various needs of the life sciences and other industries. AMRI SMARTSOURCING™ is a series of strategic sourcing options for customers to reach more successful outcomes. SMARTSOURCING™ is based on 21 years of industry-leading experience and global locations, and combines high quality scientific performance and enhanced decision-making with the accountability of delivering results in a cost-competitive manner.

(Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO)

Pharmaceutical companies are under pressure to deliver accelerated and increased drug discovery success with reduced budgets and resources. This can result in a loss of productivity where compromises, such as putting price before quality, scientific expertise and even manufacturing capability, are often struck. Furthermore, following substantial downsizing in the United States and Europe, many large pharmaceutical companies are losing experienced scientists with drug discovery and development expertise and relying more on their providers to fill critical knowledge gaps. As a result, CROs and CMOs need to reconsider their current service strategies to find more appropriate ways to meet the market's changing needs.

AMRI has taken this challenge and recently made significant changes to build a stronger, more agile organization for our customers. SMARTSOURCING™ is a pioneering approach for the industry that is fit for purpose in today's world and puts the power of decision making, without compromise, in the hands of the customer.

SMARTSOURCING™ is a means of insourcing or outsourcing, or even a hybrid model of both, which can deliver high quality performance and scientific expertise, built on a foundation of 21 years of accomplishment delivering customer IND candidates and API manufacturing successes. It means tapping into AMRI's people, knowhow, facilities, expertise and global project management to provide exactly what is needed across the discovery, development and manufacturing process.

"Pharma companies are looking for more supplier accountability, greater trust and consultation," said Thomas E. D'Ambra, Ph.D., President and CEO of AMRI. "They want a better balance of risk, but also greater flexibility and tailored business models that address their unique needs."

Dr. D'Ambra continued, "With SMARTSOURCING™, we offer customers innovative and strategic collaborative partnerships, without compromising quality or lowering expectations. We look forward to working with our customers as we continue to provide creative and flexible outsourcing solutions."

About AMRI

Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development, and manufacturing services. For over 21 years AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in the United States, Europe and Asia now provides our customers with SMARTSOURCING™, a full range of value-added opportunities providing customers informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development.


'/>"/>
SOURCE AMRI
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Neogen launches the fastest molecular pathogen test
2. Roche Launches 454 Sequencing Assays for High Sensitivity Genetic Variant Detection in Leukemia Samples to Drive Blood Cancer Research Worldwide
3. Novartis launches the Cancer Cell Line Encyclopedia to catalog worlds cancer cell lines
4. MO BIO Laboratories, Inc. Launches the PowerMicrobiome™ RNA Isolation Kit
5. Cellectricon Launches Dynaflow® Resolve System Enabling Novel Ion Channel Assays
6. Campbell Alliance Launches Market Research and Analytics Group, Appoints Michael Turner as General Manager of Encuity Research
7. Marken Launches Exclusive Shipping System for Specimen Logistics
8. Systems Alliance Launches Redesigned Website for The Living Legacy Foundation of Maryland
9. Dyadic International Launches FibreZyme® G5000 High Performance Powder Pulp and Paper Enzyme in Booth #1065 at Tissue World Americas Conference
10. Nycomed, a Takeda Company, Launches Omnaris® Nasal Spray in the UAE for the Treatment of Allergic Rhinitis
11. Berg Diagnostics Receives CLIA Certification and Launches Novel Vitamin D Assay
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):